The main result a trial was designed to measure, chosen in advance. Results on secondary outcomes are more likely to be chance findings, especially if the primary outcome showed no benefit.
Glossary
The language of light therapy research.
Papers on photobiomodulation are full of abbreviations, units and study designs. This is what the terms mean, and how to read them.
Common abbreviations
- ADHDAttention-deficit/hyperactivity disorder
- AMDAge-related macular degeneration
- ATPAdenosine triphosphate
- CBFCerebral blood flow
- CCOCytochrome c oxidase
- CIConfidence interval
- DOIDigital object identifier
- DOMSDelayed onset muscle soreness
- EEGElectroencephalography
- FIRFar-infrared
- fMRIFunctional magnetic resonance imaging
- fNIRSFunctional near-infrared spectroscopy
- HILTHigh-intensity laser therapy
- iPBMIntranasal photobiomodulation
- J, WJoule and watt
- J/cm²Fluence
- LEDLight-emitting diode
- LLLTLow-level laser therapy
- MCIMild cognitive impairment
- MCIDMinimal clinically important difference
- MoCAMontreal Cognitive Assessment
- NIRNear-infrared
- nmNanometer
- NONitric oxide
- PBMPhotobiomodulation
- PBMTPhotobiomodulation therapy
- PDTPhotodynamic therapy
- PMIDPubMed identifier
- PTSDPost-traumatic stress disorder
- RCTRandomized controlled trial
- RLRLRepeated low-level red light
- RLTRed light therapy
- ROSReactive oxygen species
- TBITraumatic brain injury
- tDCSTranscranial direct current stimulation
- TMSTranscranial magnetic stimulation
- tPBMTranscranial photobiomodulation
- UVUltraviolet
- VASVisual analogue scale
A
- Adenosine triphosphateATP
The molecule cells use to store and spend energy. Many explanations of photobiomodulation propose that light increases ATP production in the mitochondria.
- Adverse event
Any unwanted medical event that happens during a study, whether or not the treatment caused it. How carefully a trial reports adverse events is one sign of its quality.
- Age-related macular degenerationAMD
A leading cause of vision loss in older adults, in which the center of the retina is damaged. At least one PBM device has received US FDA authorization for early dry AMD.
- Alzheimer’s disease
A progressive brain disease and the most common cause of dementia. It starts with memory loss and gradually affects thinking, language and daily life. Photobiomodulation has been studied in small early trials and in animals, and it is not an established treatment.
- Androgenetic alopecia
Pattern hair loss, the most common cause of hair thinning. Some low-level light devices, such as caps and combs, have received US FDA clearance for it. Trials show modest effects.
- Angiogenesis
The growth of new blood vessels. It matters for wound healing and is one of the effects that PBM is proposed to influence, mostly based on laboratory studies.
- Anxiety
Persistent fear or worry that is out of proportion to the situation and interferes with daily life. Anxiety disorders are among the most common mental health conditions. Studies of photobiomodulation for anxiety are few and small.
- Arndt-Schulz law
A 19th century rule that weak stimuli speed up biological activity, moderate ones raise it most, and strong ones slow it down. PBM researchers cite it to explain the biphasic dose response.
- At-home device
A device made for personal use without a clinician, often with lower power and less supervision than clinical equipment. Dose, safety and real output vary between consumer products.
- Attention-deficit/hyperactivity disorderADHD
A neurodevelopmental condition marked by lasting difficulty with attention, activity levels and impulse control, starting in childhood and often continuing into adulthood. Research on photobiomodulation for ADHD is very limited.
- Attrition
Participants leaving a study before it ends. If many drop out, or more drop out of one group, the results can be biased.
- Autism
A lifelong neurodevelopmental difference in how a person communicates, interacts and processes sensory information. Many autistic people and their families do not see it as something to be cured. Studies of photobiomodulation in autism are few and small, and what outcomes matter is debated.
B
- Beam area
Also called spot size. The area of skin that the light covers, in square centimeters. The same power spread over a smaller area gives a higher irradiance, so a paper that leaves out the area leaves the dose unclear.
- Biohacking
Self-experimentation with diet, supplements, sleep, wearables and devices to improve the body or mind. It ranges from sensible habits to unproven or risky practices. Red light devices are a popular biohacking tool, and the quality of evidence behind individual claims varies widely.
- Biomarker
A measurable sign in the body, such as a blood level or a brain scan result, used as an indicator of a condition or of response to treatment. A change in a biomarker does not always mean the patient feels better.
- Biphasic dose response
The pattern in which too little light does nothing, a moderate amount helps, and too much reduces or reverses the benefit. It is often linked to the Arndt-Schulz law. It helps explain why studies that use different doses reach conflicting results.
- Blinding
Keeping people unaware of who receives the real treatment and who receives the sham. In a single-blind study the participants do not know. In a double-blind study the researchers who measure the results do not know either. It reduces bias.
- Brain fog
An informal description of foggy thinking: trouble concentrating, memory lapses and mental slowness. It is not a medical diagnosis and has many possible causes, including poor sleep, stress, illness and long COVID.
- Brain injury
Damage to the brain after birth. It includes traumatic brain injury from a blow to the head, stroke, and damage from a lack of oxygen. Effects range from brief symptoms to long-term changes in thinking, movement and mood.
- Brain waves
Rhythmic electrical activity of the brain, recorded with EEG (electroencephalography). It is grouped into bands by frequency: delta (about 0.5 to 4 Hz), theta (4 to 8), alpha (8 to 13), beta (13 to 30) and gamma (above 30). Some PBM studies record brain waves before and after treatment.
- Bright light therapy
Sitting in front of a very bright, mostly white light box, typically around 10,000 lux, mainly for seasonal depression and body clock problems. It works through the eyes and the brain's internal clock, and is a different approach from PBM.
- Burns and overheating
Skin injury from a device that gets too hot or delivers too much power. Correctly dosed PBM should not noticeably heat the skin, so warmth or burns point to an excessive dose or a faulty device.
C
- Case report
A description of one patient or a small number of patients. It can raise ideas worth testing, but it cannot show whether a treatment works.
- CE mark
A marking by which a manufacturer declares that a product meets European safety and health requirements. For many low-risk devices the manufacturer assesses this itself, so it is not proof that the device works.
- Cerebral blood flowCBF
The amount of blood reaching the brain. Some tPBM studies measure it, because light might widen blood vessels. A change in blood flow does not by itself show a benefit for thinking or symptoms.
- Chromophore
A molecule that absorbs light and starts a chemical response. Also called a photoacceptor. Identifying which chromophores matter in photobiomodulation is central to the debate about how it works.
- Clinical-grade
A marketing phrase with no official meaning. It suggests higher quality, but it says nothing about regulatory clearance or trial evidence. Check the actual specifications and the studies behind a product.
- Cognitive decline
A fall in memory, attention or reasoning skills. Some decline is a normal part of aging, and a faster or larger decline can signal a condition such as dementia.
- Cognitive test
A standardized task that measures thinking skills such as memory, attention or processing speed. Scores can rise simply because a person repeats the test (the practice effect), so trials compare against a sham group.
- Cold laser
An informal name for low-level laser therapy, used because the light does not noticeably heat the tissue. It is not a scientific term, but it is common in clinics and in product marketing.
- Collagen
The main structural protein in skin, tendons and joints. Several skin studies of light therapy measure collagen, and higher collagen markers do not always mean a visible difference.
- Confidence intervalCI
A range of values that is likely to contain the true effect, usually at the 95 percent level. A narrow interval means a precise estimate and a wide one means a lot of uncertainty. If the interval includes no effect, the result is not statistically significant.
- Conflict of interest
A financial or other tie that could influence how a study is run or reported, such as a company funding the trial or the authors selling the device. Papers list these in a disclosure statement. It does not mean the results are wrong, but it is a reason to read more carefully.
- Continuous wave and pulsed light
Continuous wave light stays on for the whole session. Pulsed light switches on and off at a set rate. Whether either approach is better is not settled, and many papers do not report the pulse settings clearly.
- Contraindication
A situation in which a treatment should not be used because it could cause harm. Anyone considering light therapy with a health condition or medication should check with a clinician first.
- Control group
The group in a trial that does not receive the treatment being tested. It may receive a sham, usual care or nothing, and it provides the comparison that shows whether the treatment made a difference.
- Crossover study
A study in which every participant receives both the active and the comparison treatment, in a random order and with a gap between them. Each person acts as their own control.
- Cytochrome c oxidaseCCO
An enzyme in the mitochondria and the leading candidate for the molecule that absorbs red and near-infrared light in cells. Absorbing light is thought to change how the enzyme works and so affect energy production. It is a hypothesis under study, and other mechanisms have also been proposed.
D
- Delayed onset muscle sorenessDOMS
The ache that peaks a day or two after unfamiliar or hard exercise. It is a common outcome in PBM studies of sport and recovery.
- Dementia
An umbrella term for a decline in memory and thinking severe enough to interfere with daily life. Alzheimer’s disease is the most common cause.
- Depression
A mood condition in which low mood or loss of interest lasts for weeks or longer and affects daily life. Some small trials have tested transcranial photobiomodulation for depression. Larger, well-controlled trials are needed.
- Diabetic foot ulcer
A slow-healing open sore on the foot of a person with diabetes, caused by poor circulation and nerve damage. PBM is being studied as a way to speed wound healing.
- Digital object identifierDOI
A permanent code and web link for a published paper. Every item on this site links to the full paper through its DOI where one exists.
- Dose
Used loosely for the amount of light delivered. Some papers mean fluence, others total energy in joules, others the whole treatment schedule. Always check which meaning a paper is using before comparing results.
- Dose-response relationship
How the size of an effect changes with the amount of treatment. A clear dose-response supports a real effect. In PBM the relationship can be biphasic, so more is not always better.
- Dosimetry
The measurement and calculation of the light dose delivered to tissue: wavelength, irradiance, beam area, time and fluence. Poor dosimetry reporting is one of the main reasons PBM studies are hard to compare.
- Dry eye
A condition in which the eyes do not make enough tears or tears evaporate too quickly, causing irritation. Light-based treatments aimed at the eyelid glands are in use and under study.
- Duty cycle
For pulsed light, the share of each cycle during which the light is on, given as a percentage. A 50 percent duty cycle means the light is on half the time, so the average power is half the peak power.
E
- Effect size
How large the difference between groups is, not only whether there is one. A result can be statistically significant and still too small to matter to a patient.
- ElectroencephalographyEEG
A method of recording the brain’s electrical activity through sensors on the scalp. It is painless, and it is used in some tPBM studies to look for changes in brain waves.
- Eye protection
Goggles, closed eyes or a device design that keeps light out of the eyes during treatment. Studies and manufacturers should say how the eyes are protected, especially for lasers and for devices worn on the head.
F
- Far-infraredFIR
Infrared light with longer wavelengths than near-infrared, which mostly feels like heat. Infrared saunas and heat lamps use it. It acts largely by warming the body rather than by the mechanisms proposed for PBM.
- FDA 510(k) clearance
A US Food and Drug Administration decision that a device is substantially equivalent to one already on the market for a stated use. It is not a finding that the device works for any particular condition.
- FDA device classes
The US FDA sorts medical devices into three classes by risk. Class I is the lowest risk and Class III the highest. Most light therapy devices are Class II, which usually go through 510(k) clearance.
- Fibromyalgia
A long-term condition of widespread pain, fatigue and sleep problems. Small trials have tested PBM for fibromyalgia, with mixed results.
- Fitzpatrick scale
A six-point scale of how skin reacts to sun, from type I (always burns, very fair) to type VI (rarely burns, very dark). Studies use it to describe participants’ skin, which matters because melanin absorbs light.
- FluenceJ/cm²
Also called energy density. The total light energy delivered to each square centimeter of tissue, measured in joules per square centimeter. It equals irradiance (in watts per square centimeter) multiplied by the treatment time in seconds.
- Functional magnetic resonance imagingfMRI
A type of brain scan that tracks changes in blood flow as a marker of activity. Used to see which brain regions respond to a task or treatment. Changes on a scan do not always mean a change in how a person feels or functions.
- Functional near-infrared spectroscopyfNIRS
A method of measuring changes in blood oxygen in the brain by shining weak near-infrared light through the scalp and detecting how much returns. It uses similar light to tPBM but is used to measure, not to treat.
G
- GRADE
A system for rating how certain we can be about a body of evidence: high, moderate, low or very low. Reviews use it to say how far results are likely to hold up in practice.
H
- Handheld probe
A small laser or LED device held against a specific spot, such as a joint, wound or the inside of the mouth. Probes deliver light to a small area, so treatment time and the area covered matter for the dose.
- Heterogeneity
Variation between the studies in a review, caused by different doses, wavelengths, populations or methods. When it is high, pooled results should be treated with caution. It is common in PBM research.
- High-intensity laser therapyHILT
Treatment with much more powerful lasers than those used in PBM, often strong enough to warm tissue. It is a different treatment, and results from one cannot be applied to the other.
- Hormesis
A response in which a low dose of something is beneficial and a high dose is harmful or has no effect. It is often used to describe the biphasic dose response in PBM.
I
- In vitro and animal research
Also called preclinical research. In vitro studies use cells in a dish, and animal studies use laboratory animals. They are useful for exploring mechanisms, but results often do not carry over to people.
- Inflammation
The body’s response to injury or infection, with redness, swelling, warmth and pain. Short-term inflammation helps healing, and long-term inflammation can cause harm. Reducing it is a common explanation offered for PBM effects.
- Insomnia
Ongoing difficulty falling asleep or staying asleep despite the chance to sleep, with effects on daytime function. Research on photobiomodulation and sleep is early.
- Intention-to-treat analysis
Analyzing participants in the group they were originally assigned to, even if they dropped out or did not follow the treatment. It protects the benefit of randomization and avoids making results look better than they were.
- Intranasal photobiomodulationiPBM
Light delivered through the nostrils, usually from a small red or near-infrared LED. It has been proposed as a simple way to influence the brain and circulation. The evidence is early.
- Irradiance
Power density. How much light power falls on each square centimeter of skin, measured in milliwatts per square centimeter (mW/cm²). Sometimes called intensity.
J
- Joule and wattJ, W
A joule is a unit of energy and a watt is a unit of power. One watt delivers one joule every second. A device's power in watts says how fast it delivers light, and joules say how much it delivered in total.
L
- Laser
A light source that produces a narrow beam of a single wavelength in which the light waves move in step. Lasers were used in the earliest photobiomodulation work and are still used in clinics.
- LED helmet
A wearable device with LEDs, usually near-infrared, built into a helmet shape to shine light on the scalp. Used in tPBM research and sold for home use. How much light reaches the brain depends on wavelength, power and skull thickness.
- Light panel
A flat board of LEDs, typically red and near-infrared, used for larger areas of the body from a short distance. Panels are common in consumer devices, and their real output varies widely between products.
- Light-emitting diodeLED
A light source that is cheaper than a laser, covers a slightly wider range of wavelengths and spreads its beam more. Most consumer devices use LEDs. Whether the difference from lasers matters in practice is debated, and many researchers argue that wavelength and dose matter more.
- Long COVID
Symptoms that continue or appear weeks to months after a COVID-19 infection, such as fatigue, breathlessness and brain fog. Also called post-COVID condition. Photobiomodulation has been tried in a few small studies.
- Longevity
The study and promotion of living longer, and increasingly of staying healthy for longer (healthspan). The term is used loosely in marketing. Some cell and animal studies explore light and aging, but no human trial has shown that photobiomodulation extends lifespan.
- Low-level laser therapyLLLT
Also called low-level light therapy. An older name for what is now usually called photobiomodulation. It is still common in older papers, so we search for both terms.
- Lux
A unit of how bright light looks to the human eye. Because it is weighted to visible light, it says little about the energy of red or near-infrared light, so it is not a useful measure of PBM dose.
M
- Melanin
The pigment that gives skin its color. It absorbs light, so in darker skin less red light may reach deeper tissue, which could affect the dose needed. Many trials do not report skin tone.
- Mental acuity
An informal term for how sharp thinking feels: attention, memory, processing speed and clear reasoning. It is not a diagnosis. In studies it is measured with specific tests rather than the general term.
- Meta-analysis
A statistical method that pools the results of several studies into one overall estimate. It is only as reliable as the studies it combines, and it can be misleading if those studies used very different doses or methods.
- Migraine
A recurring headache disorder, often with nausea and sensitivity to light and sound. Some small studies have tested PBM for migraine, and the evidence is early.
- Mild cognitive impairmentMCI
A noticeable decline in memory or thinking that is more than normal aging but does not seriously interfere with daily life. Some people with it go on to develop dementia, and some do not.
- Minimal clinically important differenceMCID
The smallest change that patients would notice as meaningful. A treatment can beat sham by a measurable amount and still fall short of this threshold.
- Mitochondria
Structures inside cells that produce most of the energy a cell uses. Most proposed explanations of how photobiomodulation works start here.
- Montreal Cognitive AssessmentMoCA
A 30-point screening test of memory, attention, language and reasoning, widely used to detect mild cognitive impairment. Higher scores indicate better performance.
- Myopia
Nearsightedness, in which distant objects look blurry because the eye grows too long. It often starts in childhood and tends to get worse through the teenage years.
N
- Nanometernm
One billionth of a meter, and the unit used to give a light's wavelength. Visible light runs from about 400 nanometers (violet) to about 700 nanometers (red). Red light used in PBM is typically 620 to 700 nm, and near-infrared is roughly 780 to 1100 nm.
- Near-infraredNIR
Light just beyond visible red, roughly 780 to 1100 nanometers in this field. You cannot see it. It generally travels deeper into tissue than visible red light, which is why it is used for deeper targets such as joints and the brain.
- Negative result
A study that finds no benefit or no difference. Negative results are as informative as positive ones, but they are published less often, which can distort the picture.
- Neurofeedback
Also called neural feedback or EEG biofeedback. A person watches or hears a live display of their own brain activity and learns to shift it. It is a different approach from PBM, though the two are sometimes combined or offered side by side.
- Neuroinflammation
Inflammation in the brain and nervous system. It is involved in many brain conditions, and some researchers think photobiomodulation might reduce it. That idea comes mostly from cell and animal studies.
- Neuromodulation
Changing nerve activity with electricity, magnets, drugs or light. TMS and tDCS are well-known examples. PBM is sometimes described as neuromodulation, though how it acts on nerve cells is still being studied.
- Neuronic
A company that makes and sells at-home near-infrared photobiomodulation helmets. Neuronic owns and funds this site. This site does not rate or recommend products, including Neuronic’s. See the About page.
- Neuropathy
Nerve damage that causes numbness, tingling or pain, often in the hands and feet. It is common in diabetes and after some cancer treatments. PBM has been studied for it, with early and mixed evidence.
- Neuroplasticity
The brain’s ability to change its connections in response to experience, learning or injury. It is often mentioned as a possible route by which treatments help recovery, and it is hard to prove in people.
- Neurotechnology
Devices that record or influence the nervous system, including EEG headsets, neurofeedback, brain stimulation and some light therapy devices.
- Nitric oxideNO
A molecule that helps blood vessels widen. One proposed mechanism is that light frees nitric oxide that is bound to cytochrome c oxidase, which may improve blood flow and let the enzyme work normally again.
- Nootropic
A substance or tool claimed to improve thinking, memory or focus. The word has no regulatory meaning, and claims often run ahead of the evidence.
O
- Observational study
A study that watches what happens without assigning treatment, such as following people who already use light therapy. It can find associations but cannot prove that the treatment caused them.
- Off-label use
Using a cleared or approved product for a purpose that its clearance does not cover. It is legal for clinicians to do this in many cases, but it means a regulator has not reviewed the device for that use.
- Open-label study
A study in which participants and researchers both know who is receiving the treatment. It is more open to bias than a blinded study, because expectations can influence the results.
- Optical window
A band of wavelengths, roughly red to near-infrared, that blood and water absorb less than other colors, so the light travels further into tissue. It is the main reason PBM uses these wavelengths.
- Oral mucositis
Painful inflammation and ulcers of the lining of the mouth, a common side effect of some cancer treatments. It is one of the better-studied uses of photobiomodulation, and some clinical guidelines include light therapy for prevention.
- Osteoarthritis
A joint condition in which cartilage wears down, causing pain and stiffness, most often in the knees, hips and hands. It is a frequent target of PBM trials.
- Oxidative stress
Damage that occurs when reactive oxygen species build up faster than cells can neutralize them. It is linked to aging and many diseases. Some PBM studies measure markers of it.
P
- Parkinson’s disease
A condition in which the brain cells that make dopamine are gradually lost, causing tremor, stiffness and slow movement. Photobiomodulation research for Parkinson’s is mostly in animals and small human studies.
- Peer review
The process in which independent experts check a paper before a journal publishes it. It catches many problems but not all, and it is not a guarantee that a finding is correct.
- Penetration depth
How far light travels into tissue before most of it is absorbed or scattered. It depends on wavelength, skin tone, fat thickness and the part of the body. It is a major challenge for studies that target the brain or deep joints.
- PhotobiomodulationPBM
The use of low levels of red or near-infrared light to influence how cells work, without heating tissue enough to damage it. Researchers agreed on the name in the mid 2010s to replace older terms such as low-level laser therapy.
- Photobiomodulation therapyPBMT
The clinical use of photobiomodulation as a treatment. Papers often use the term for the intervention itself, and in practice it means the same as PBM.
- Photodynamic therapyPDT
A treatment that combines light with a drug that becomes active when light reaches it, used to destroy targeted cells such as some skin cancers and precancerous lesions. It works differently from PBM, which uses no drug and aims to stimulate cells rather than destroy them.
- Photon
The smallest unit of light. Each photon carries an amount of energy that depends on its wavelength, with shorter wavelengths carrying more. Any effect of PBM depends on photons actually being absorbed by cells.
- Photoreceptor
A cell in the retina, such as a rod or cone, that detects light so we can see. Not the same as a photoacceptor (chromophore) inside other cells, which absorbs light without producing vision. The two terms are easy to confuse.
- Photosensitive epilepsy
A form of epilepsy in which flashing or flickering light can trigger seizures. Pulsed light devices raise a possible concern, so people with epilepsy should ask a clinician before using one.
- Photosensitizing medication
Drugs that make skin or eyes more sensitive to light, including some antibiotics and acne treatments. They are relevant when judging whether light therapy is safe for a particular person.
- Phototherapy
Treatment with light in general. It includes ultraviolet light for some skin conditions, blue light for newborn jaundice and bright light for seasonal depression. Photobiomodulation is one branch of it.
- Photothermal effect
Heating of tissue caused by absorbed light. PBM doses are meant to be low enough to avoid it, and a device that noticeably heats the skin is working in a different regime.
- Pilot study
A small early study that tests whether an approach is feasible. It can suggest ideas worth testing, but it is rarely large enough to show that a treatment works.
- Placebo effect
Benefit that comes from expecting a treatment to work rather than from the treatment itself. It can be strong in studies of pain and mood, which is why sham-controlled trials matter.
- Placebo-controlled
A trial in which the comparison group receives an inactive treatment. In light therapy trials the placebo is a sham device.
- Post-traumatic stress disorderPTSD
A condition that can follow a frightening or traumatic event, with intrusive memories, avoidance, negative changes in mood and thinking, and feeling constantly on edge for more than a month. Photobiomodulation research on PTSD is small and early.
- Power output
The total light power a device emits, in watts. It is not the same as irradiance. A large panel can have a high power output but a low irradiance at the skin.
- Preprint
A paper shared publicly before peer review. Preprints can appear months before the final version, and their findings may change or be withdrawn.
- Preregistration
Publicly stating a study’s plan, including its main question and analysis methods, before collecting data. It stops researchers from changing the question after seeing the results. Trial registration is the clinical version.
- Primary outcome
- Publication bias
The tendency for studies with positive results to be published more often than studies with negative or null results. It can make a treatment look better than it is.
- PubMed identifierPMID
The unique number of a record in PubMed, the main database of biomedical literature. It can be used to find the full paper.
R
- Randomized controlled trialRCT
A study in which participants are assigned by chance to the treatment group or a comparison group. It is the strongest single-study design for testing whether a treatment works, though small or badly run trials can still mislead.
- Reactive oxygen speciesROS
Chemically active molecules made during normal cell metabolism. In small amounts they act as signals, and in large amounts they damage cells. Light is proposed to cause a brief, small rise that triggers protective responses.
- Red light therapyRLT
A consumer term for photobiomodulation with visible red light, typically around 620 to 700 nanometers. It is often used loosely to include near-infrared light as well.
- Repeated low-level red lightRLRL
A treatment for childhood nearsightedness in which a child looks into a red light for a few minutes, a few times a day. It has been studied as a way to slow the growth of the eye. Questions about safety for the retina are under discussion.
- Replication
Another research group repeating a study and finding a similar result. A finding that independent teams have reproduced is more trustworthy than one from a single study.
- Retina
The light-sensitive layer at the back of the eye. Light that is too intense can damage it, which is why eye safety is assessed for any light device used near the face.
- Retraction
The withdrawal of a published paper by a journal because of error, misconduct or another serious problem. Retracted papers should not be relied on.
- Risk of bias
The chance that flaws in how a study was designed or run pushed its results in one direction. Reviews rate it by looking at randomization, blinding, missing data and selective reporting.
S
- Sample size
The number of participants in a study. Small studies are more likely to produce chance results and to miss real effects.
- Sham
An inactive version of a treatment designed to look and feel real, such as a device that lights up but delivers almost no energy. It lets researchers separate the effect of the light from the effect of expectation.
- Sham device
A device built to look and behave like the real one, with lights, sounds and a timer, but that delivers no light or a negligible amount. Participants in a sham-controlled trial use it so that they cannot tell which treatment they received. A sham that is easy to spot undermines the blinding.
- Spectral output
Which wavelengths a device actually emits and how much light comes out at each. LEDs usually emit a band around their stated peak, and measured output can differ from the specification on the box.
- Statistical significance
A result is called statistically significant when it would be unlikely to appear by chance alone if the treatment did nothing, usually when p is below 0.05. It does not mean the effect is large or important, and it is easy to over-read in small studies.
- Stroke
Brain damage caused by a blocked or burst blood vessel. Early studies of transcranial light therapy for stroke were promising, but a large trial of transcranial laser therapy did not confirm a benefit.
- Systematic review
A review that searches for all relevant studies using a stated method and judges their quality, rather than picking studies selectively. It gives a more reliable overview than a single paper.
T
- Tendinopathy
Pain and reduced function in a tendon from overuse or injury, such as in the elbow, heel or shoulder. A common target of PBM trials.
- Tinnitus
Ringing or other noise in the ears with no outside source. Studies of light therapy for tinnitus are small and early.
- Transcranial direct current stimulationtDCS
A technique that passes a weak electrical current through the scalp to nudge brain activity. It is a different technology from PBM, and the two are sometimes compared in neuromodulation research.
- Transcranial magnetic stimulationTMS
A treatment that uses magnetic pulses from a coil on the scalp to stimulate parts of the brain. It is approved for some uses, such as treatment-resistant depression. It is a different technology from PBM.
- Transcranial photobiomodulationtPBM
Light, usually near-infrared, shone through the scalp and skull toward the brain. It is being studied for memory, stroke, brain injury and mood. How much light actually reaches brain tissue is an active research question.
- Traumatic brain injuryTBI
Damage to the brain from a blow or jolt to the head, ranging from concussion to severe injury. PBM, especially tPBM, is being studied as an aid to recovery.
- Trial registration
Entering a trial in a public registry such as ClinicalTrials.gov before it starts, with its planned methods and main outcome. It lets readers check whether the researchers later changed what they reported.
U
- UltravioletUV
Light with wavelengths shorter than visible violet, below about 400 nanometers. It can damage skin and eyes. It is not part of photobiomodulation.
V
- Visual analogue scaleVAS
A line, often 100 millimeters long, on which a patient marks their pain or another symptom from none to the worst imaginable. It is widely used in pain trials.
W
- Wavelength
The distance between the peaks of a light wave, measured in nanometers (nm). It sets the color of the light and how deeply it travels and what it interacts with. A paper that does not state its wavelength cannot be reproduced.
- Wellness
A broad marketing and lifestyle term for efforts to feel and function better. It is not a medical category. Devices sold for general wellness may face lighter regulation than medical devices, so a wellness claim is not evidence that a device works.
- Wound healing
The body’s process of closing and repairing damaged skin. PBM is studied for speeding it up, including in diabetic foot ulcers, surgical wounds and burns.